4.7 Article

Derivation and Use of Cell Lines from Mouse Models of Melanoma

Related references

Note: Only part of the references are listed.
Editorial Material Dermatology

Research Techniques Made Simple: Zebrafish Models for Human Dermatologic Disease

William Tyler Frantz et al.

Summary: Skin diseases affect almost one third of the world's population, with severe outcomes including death and disfigurement. Zebrafish models, with their rapid development, comparable skin architecture, tractable genetics, unparalleled optical properties, and straightforward drug screens, have become an excellent model for studying skin diseases.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2022)

Article Biochemistry & Molecular Biology

Single-cell RNA sequencing reveals the existence of pro-metastatic subpopulation within a parental B16 murine melanoma cell line

Yoon-Seob Kim et al.

Summary: This study provides insight into the mechanism of melanoma metastasis at the single-cell level. Differential gene expression analysis identified upregulated genes related to metastasis and downregulated genes in the Mitf pathway. The proportion of cycling cells and high expression of specific genes were closely associated with the metastatic ability of melanoma cells. The evolution of cell populations during metastasis showed distinct characteristics and unique metastatic potential. Genomic alterations, including shared mutations and specific changes, contributed to the development of metastasis in melanoma.

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2022)

Article Multidisciplinary Sciences

BRN2 is a non-canonical melanoma tumor-suppressor

Michael Hamm et al.

Summary: BRN2 is a key transcription factor that regulates melanoma invasion, but its role in melanoma initiation was previously unclear. This study shows that BRN2 acts as a haplo-insufficient tumor suppressor that positively regulates PTEN expression, and in the context of BRAF mutation and heterozygous PTEN, loss of BRN2 promotes melanoma initiation and progression.

NATURE COMMUNICATIONS (2021)

Article Cell & Tissue Engineering

Dual Inhibitors-Loaded Nanotherapeutics that Target Kinase Signaling Pathways Synergize with Immune Checkpoint Inhibitor

Anujan Ramesh et al.

CELLULAR AND MOLECULAR BIOENGINEERING (2019)

Article Cell Biology

Translational reprogramming marks adaptation to asparagine restriction in cancer

Gaurav Pathria et al.

NATURE CELL BIOLOGY (2019)

Review Oncology

Targeted agents and immunotherapies: optimizing outcomes in melanoma

Jason J. Luke et al.

NATURE REVIEWS CLINICAL ONCOLOGY (2017)

Article Oncology

The YUMM lines: a series of congenic mouse melanoma cell lines with defined genetic alterations

Katrina Meeth et al.

PIGMENT CELL & MELANOMA RESEARCH (2016)

Article Oncology

Multiple murine BRaf V600E melanoma cell lines with sensitivity to PLX4032

Molly H. Jenkins et al.

PIGMENT CELL & MELANOMA RESEARCH (2014)

Article Biochemistry & Molecular Biology

MDM4 is a key therapeutic target in cutaneous melanoma

Agnieszka Gembarska et al.

NATURE MEDICINE (2012)

Article Pathology

Modèles murins de mélanomes cutanés. Importance du fond génétique

Christine Longvert et al.

ANNALES DE PATHOLOGIE (2011)

Article Oncology

p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation

Tamara Terzian et al.

PIGMENT CELL & MELANOMA RESEARCH (2010)

Article Oncology

Oncogenic Braf Induces Melanocyte Senescence and Melanoma in Mice

Nathalie Dhomen et al.

CANCER CELL (2009)

Article Genetics & Heredity

BrafV600E cooperates with Pten loss to induce metastatic melanoma

David Dankort et al.

NATURE GENETICS (2009)

Article Dermatology

Examination of mutations in BRAF, NRAS, and PTEN in primary cutaneous melanoma

Vikas K. Goel et al.

JOURNAL OF INVESTIGATIVE DERMATOLOGY (2006)